IFNA1 and glioblastoma: Notably, m6A-regulated IFN responses in GBM reduce Treg infiltration and strengthen the efficacy of ICB by targeting transcription elongation machinery [138], revealing a novel mechanism by which m6A regulates the immune-suppressive TIME and the molecular basis of therapy resistance in GBM.